Search by Drug Name or NDC

    NDC 00004-0259-43 CellCept 250 mg/1 Details

    CellCept 250 mg/1

    CellCept is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Genentech, Inc.. The primary component is MYCOPHENOLATE MOFETIL.

    Product Information

    NDC 00004-0259
    Product ID 0004-0259_0ab859a2-aff9-4df4-bd01-3d687d27239a
    Associated GPIs 99403030100120
    GCN Sequence Number 023724
    GCN Sequence Number Description mycophenolate mofetil CAPSULE 250 MG ORAL
    HIC3 Z2E
    HIC3 Description IMMUNOSUPPRESSIVES
    GCN 47560
    HICL Sequence Number 010012
    HICL Sequence Number Description MYCOPHENOLATE MOFETIL
    Brand/Generic Brand
    Proprietary Name CellCept
    Proprietary Name Suffix n/a
    Non-Proprietary Name Mycophenolate Mofetil
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name MYCOPHENOLATE MOFETIL
    Labeler Name Genentech, Inc.
    Pharmaceutical Class Antimetabolite Immunosuppressant [EPC]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA050722
    Listing Certified Through 2024-12-31

    Package

    NDC 00004-0259-43 (00004025943)

    NDC Package Code 0004-0259-43
    Billing NDC 00004025943
    Package 1 BOTTLE, PLASTIC in 1 CARTON (0004-0259-43) / 500 CAPSULE in 1 BOTTLE, PLASTIC
    Marketing Start Date 1995-05-03
    NDC Exclude Flag N
    Pricing Information N/A